- Home
- SEDG vs DYN Comparison
SEDG vs DYN Comparison
Compare SEDG & DYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEDG
- DYN
- Stock Information
- Founded
- SEDG 2006
- DYN 1984
- Country
- SEDG Israel
- DYN United States
- Employees
- SEDG N/A
- DYN N/A
- Industry
- SEDG Semiconductors
- DYN Medicinal Chemicals and Botanical Products
- Sector
- SEDG Technology
- DYN Health Care
- Exchange
- SEDG Nasdaq
- DYN Nasdaq
- Market Cap
- SEDG 2.4B
- DYN 1.9B
- IPO Year
- SEDG 2015
- DYN 2020
- Fundamental
- Price
- SEDG $34.63
- DYN $21.11
- Analyst Decision
- SEDG Sell
- DYN Strong Buy
- Analyst Count
- SEDG 20
- DYN 15
- Target Price
- SEDG $25.92
- DYN $36.53
- AVG Volume (30 Days)
- SEDG 4.9M
- DYN 3.2M
- Earning Date
- SEDG 11-05-2025
- DYN 11-05-2025
- Dividend Yield
- SEDG N/A
- DYN N/A
- EPS Growth
- SEDG N/A
- DYN N/A
- EPS
- SEDG N/A
- DYN N/A
- Revenue
- SEDG $1,045,303,000.00
- DYN N/A
- Revenue This Year
- SEDG $35.00
- DYN N/A
- Revenue Next Year
- SEDG $16.11
- DYN N/A
- P/E Ratio
- SEDG N/A
- DYN N/A
- Revenue Growth
- SEDG 2.35
- DYN N/A
- 52 Week Low
- SEDG $10.41
- DYN $6.36
- 52 Week High
- SEDG $48.60
- DYN $31.32
- Technical
- Relative Strength Index (RSI)
- SEDG 44.96
- DYN 58.23
- Support Level
- SEDG $32.98
- DYN $18.20
- Resistance Level
- SEDG $37.07
- DYN $21.98
- Average True Range (ATR)
- SEDG 4.50
- DYN 1.78
- MACD
- SEDG -0.76
- DYN -0.17
- Stochastic Oscillator
- SEDG 22.87
- DYN 57.30
About SEDG SolarEdge Technologies Inc.
SolarEdge Technologies designs, develops, and sells direct current optimized inverter systems for solar photovoltaic installations. The company system consists of power optimizers, inverters, and cloud-based monitoring platform and addresses a broad range of solar market segments, from residential solar installations to commercial and small utility-scale solar installations. The company sells its products directly to solar installers, engineering, procurement, and construction firms and indirectly to solar installers through distributors and electrical equipment wholesalers.
About DYN Dyne Therapeutics Inc.
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.